Techdow Pharma England Ltd (Techdow) is committed to supporting the safe and effective use of
Inhixa® (enoxaparin sodium) through the provision of training, educational resources, and practical
support for healthcare professionals.
The purpose of this support is to help healthcare professionals develop confidence and competence in
the appropriate use of Inhixa®, including measures to support the reduction of needlestick injuries
and to provide education on correct administration techniques. Training may also support healthcare
professionals who are responsible for educating patients on the use of Inhixa®. Techdow personnel do
not have direct contact with patients.
Training may be delivered through a combination of face-to-face and online learning formats,
including access to a distance-learning platform where appropriate.
All training and support provided by Techdow is intended solely to support patient care and the safe
and effective use of Inhixa®. Such support is not intended to encourage, induce, or reward the
prescription, recommendation, purchase, supply, administration, or use of Inhixa®. All activities
are conducted in a manner that is proportionate, clinically appropriate, and consistent with the
requirements of the ABPI Code of Practice.
Transfers of Value
There is no charge to NHS organisations for training and support provided by Techdow. However, in
accordance with transparency requirements, Techdow will be required to publicly disclose certain
Transfers of Value (ToVs) provided to healthcare organisations.
A Transfer of Value is a payment or non-monetary benefit provided directly or indirectly by Techdow
to a healthcare professional or healthcare organisation.
Where applicable, Transfers of Value associated with the provision of training and support will
include the following:
- Onsite Training
- Direct training provided by Techdow staff members is a fixed cost already paid by
Techdow and as such, will not be declared as a transfer of value.
- Where it is necessary to employ third-party individuals as trainers, this will be
declared as a transfer of value to the NHS body being supported, calculated at £500
per
trainer per day.
- Online training
- Annual calculation of the cost of operating the distance learning portal, divided by
the
number of secondary care entities using Inhixa® as their primary LMWH. Secondary
care
entities are defined as English Trusts and devolved equivalents.
- An equal transfer of value figure will therefore be generated for each secondary
care
entity.
- Educational and Support Materials
- Techdow may provide educational and training materials that support the safe and
effective use of Inhixa®, including demonstration devices such as placebo syringes
and
training aids.
- The provision of such materials may be recorded and, where required under
transparency
obligations, disclosed as a Transfer of Value to the receiving healthcare
organisation.
- Safety Support Items
- In certain circumstances, and where clinically appropriate, Techdow may provide or
support items intended to facilitate the safe administration and disposal of
injectable
medicines, such as sharps disposal containers.
- Any such support is subject to internal review and approval processes and will be
disclosed as a Transfer of Value where applicable.
- Other Organisational Support
- Occasionally, additional support may be provided to healthcare organisations where
there
is a legitimate clinical or operational need and where such support complies with
applicable regulations, company procedures, and the ABPI Code of Practice. Where
relevant, this support will be subject to public disclosure requirements.
Techdow publishes annual disclosures of Transfers of Value in accordance with applicable
transparency requirements and industry standards. Techdow publishes a single annual report covering
Transfers of Value made to healthcare professionals and healthcare organisations across the United
Kingdom of Great Britain and Northern Ireland, either directly or on behalf of Techdow.
Disclosures are published on the Techdow website by June of the year following the reporting period
and will include:
- The name of the healthcare organisation receiving the support.
- The nature of the support provided.
- The associated Transfer of Value amount, where applicable.
Our Commitment
Techdow is committed to maintaining high standards of integrity, transparency, and compliance in all
interactions with healthcare organisations and healthcare professionals. Training and support
programmes are designed to enhance patient care, support the safe and effective use of medicines,
and comply with all relevant legal, regulatory, and ethical requirements.
Document Code: TD-101 v4
Date of Preparation: June 2026
